Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-10

Clinical Trial Update: Study of Ketamine Administered Intravenously and by Sublingual Wafer

View source ↗

Summary

A completed clinical study evaluating ketamine given intravenously and as a sublingual wafer for pain management has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: iX Biopharma Ltd. | Conditions: Pain | Status: COMPLETED